Skip to main content
December 10, 2018

Rasmussen joins Forward BIO Institute as assistant director

Written By: Staff


Cathy Rasmussen, an accomplished regenerative medicine and biomanufacturing researcher, has joined the recently established Forward BIO Institute at the University of Wisconsin-Madison as assistant director.

Cathy Rasmussen
Cathy Rasmussen. Photo credit: Marie She Photography.

Rasmussen, who holds a PhD from UW-Madison in cellular and molecular biology and is an inventor on four U.S. and numerous international patents, was previously part of the pioneering team at Madison biotechnology firm Stratatech, which was acquired by Mallinckrodt Pharmaceuticals in 2016. Her work was integral to developing the company’s technology and advancing its products toward commercialization.

Rasmussen will work in partnership with William Murphy, director of the Forward BIO Institute and professor of biomedical engineering and orthopedics at UW-Madison, to expedite transformation of innovative technologies into healthcare solutions with broad societal impacts and to make Wisconsin a leading national hub for biomanufacturing-focused research and development and workforce development efforts.

“I am deeply passionate about regenerative medicine and its promise to improve patient lives,” Rasmussen says. “I enthusiastically welcome the opportunity to work with UW-Madison’s world-class researchers and contribute to converting promising discoveries into transformative therapies.”

UW-Madison created the Forward BIO Institute in September 2018 as part of the Forward BIO Initiative, a partnership between the university, the state of Wisconsin and biomanufacturing industry leaders. The institute supports innovation in the emerging area of biomanufacturing to create the next generation of healthcare products such as engineered tissues, cell therapies, pharmaceuticals and medical devices.

Rasmussen will also serve as innovation lead for the Forward BIO Initiative.

“Cathy is a tremendous asset to the Forward BIO Institute and the broader Forward BIO Initiative,” says Murphy, who also serves as chair of the Initiative. “It is difficult to imagine a more experienced and capable catalyst for transformative technology development in biomanufacturing.”